Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FAAQS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,940
Award facts
- Contract value 100% obligated
- $29,939.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at approximately $29,940 by the Defense Logistics Agency on August 4, 2025. The contract calls for the delivery of 180 tablets of Entresto 24 mg-26 mg, a prescription medication used to treat heart failure, with an ultimate completion date of August 5, 2025. This is an unset-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally.
The Defense Logistics Agency's Medical Supply Chain relies on prime vendors like AmerisourceBergen to fulfill critical pharmaceutical procurement needs across the Department of Defense, Defense Health Agency, and other federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to deliver brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains through open competition. This delivery order represents one of numerous transactions under the company's primary contract vehicle, reflecting DLA's ongoing procurement of medications essential to military medical readiness and veteran healthcare support.
Quick answers
Who was awarded contract SPE2DB25FAAQS?
SPE2DB25FAAQS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FAAQS worth?
The government has obligated $29,940 on SPE2DB25FAAQS.
Is contract SPE2DB25FAAQS an order under another contract?
Yes. SPE2DB25FAAQS is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB25FAAQS competed?
The extent of competition for SPE2DB25FAAQS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award